Cooper Companies Inc Forecasted to Post Q1 2018 Earnings of $2.55 Per Share (COO)
Cooper Companies Inc (NYSE:COO) – Northcoast Research lifted their Q1 2018 earnings per share (EPS) estimates for shares of Cooper Companies in a report released on Wednesday. Northcoast Research analyst D. Keiser now anticipates that the medical device company will post earnings of $2.55 per share for the quarter, up from their prior forecast of $2.48. Northcoast Research also issued estimates for Cooper Companies’ Q2 2018 earnings at $3.02 EPS.
Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping the consensus estimate of $2.64 by $0.01. The firm had revenue of $561.50 million for the quarter, compared to the consensus estimate of $558.86 million. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The business’s quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.28 EPS.
Cooper Companies (COO) traded up $0.33 during trading hours on Friday, reaching $235.52. 578,300 shares of the company’s stock were exchanged, compared to its average volume of 547,517. The company has a current ratio of 2.41, a quick ratio of 1.26 and a debt-to-equity ratio of 0.36. The stock has a market cap of $11,620.00, a PE ratio of 31.32, a P/E/G ratio of 1.90 and a beta of 0.54. Cooper Companies has a one year low of $179.41 and a one year high of $256.39.
Several large investors have recently made changes to their positions in the business. YorkBridge Wealth Partners LLC boosted its stake in Cooper Companies by 2.1% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after purchasing an additional 11 shares during the period. Sentry Investment Management LLC raised its holdings in shares of Cooper Companies by 0.7% during the 2nd quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock valued at $671,000 after purchasing an additional 19 shares in the last quarter. Thrivent Financial For Lutherans raised its holdings in shares of Cooper Companies by 0.3% during the 2nd quarter. Thrivent Financial For Lutherans now owns 12,410 shares of the medical device company’s stock valued at $2,971,000 after purchasing an additional 40 shares in the last quarter. Suntrust Banks Inc. raised its holdings in shares of Cooper Companies by 0.6% during the 2nd quarter. Suntrust Banks Inc. now owns 6,616 shares of the medical device company’s stock valued at $1,583,000 after purchasing an additional 40 shares in the last quarter. Finally, M&T Bank Corp raised its holdings in shares of Cooper Companies by 2.1% during the 2nd quarter. M&T Bank Corp now owns 3,466 shares of the medical device company’s stock valued at $830,000 after purchasing an additional 70 shares in the last quarter. Institutional investors own 96.73% of the company’s stock.
In related news, Director Gary S. Petersmeyer sold 785 shares of the stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $229.06, for a total transaction of $179,812.10. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Robert S. Weiss sold 32,500 shares of the stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $224.70, for a total transaction of $7,302,750.00. Following the sale, the chief executive officer now owns 119,111 shares in the company, valued at approximately $26,764,241.70. The disclosure for this sale can be found here. Insiders have sold 54,385 shares of company stock worth $12,289,463 in the last ninety days. Corporate insiders own 1.60% of the company’s stock.
The business also recently declared a semiannual dividend, which will be paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd will be given a dividend of $0.03 per share. The ex-dividend date is Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s payout ratio is 0.80%.
WARNING: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/19/cooper-companies-inc-forecasted-to-post-q1-2018-earnings-of-2-55-per-share-coo.html.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.